JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 23 No. 10 895-898
© 1982 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diksic, M.
Right arrow Articles by Feindel, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diksic, M.
Right arrow Articles by Feindel, W.

Synthesis of "No Carrier Added" 1,3-Bis-(2-chloroethyl)nitrosourea (BCNU)

Mirko Diksic, Simin Farrokhzad, Lucas Yamamoto and William Feindel

Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, H3A 2B4

Correspondence: For reprints contact: Dr. M. Diksic, Medical Cyclotron Facility, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, Quebec, H3A 2B4.

ABSTRACT

A chemotherapeutic agent, C-11-labeled BCNU, has been prepared by nitrosation of C-11-labeled BCU, which was synthesized by reacting C-11-labeled phosgene with ethylenimine. Two methods of nitrosation are outlined and the results of both are discussed. The specific activity of C-11 BCNU was about 85 Ci/mmole at the end of bombardment and 30 Ci/mmole at the time of administration. Chemical and radiochemical purity of the final material was at least 98%.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1982 by the Society of Nuclear Medicine.